GO:0032675 regulation of interleukin-6 production: Cytokine Production Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032675 (regulation of interleukin-6 production) describes any biological process that modulates the frequency, rate, or extent of interleukin-6 (IL-6) production.
• IL-6 is a pleiotropic cytokine whose production is tightly controlled at transcriptional, post-transcriptional, and epigenetic levels, and dysregulation drives chronic inflammation, autoimmunity, and cancer.
• Key regulators include NF-kB, AP-1, C/EBP-beta, and epigenetic modifiers that respond to pathogen-associated and damage-associated signals.
• IL-6 production is context-dependent: exercise, depression, and metabolic stress can each alter IL-6 synthesis in distinct tissues.
• Experimental models for studying GO:0032675 include knockout, point-mutation, knock-in, and overexpression cell lines, as well as CRISPR library screening and bioinformatics.
• The term is a biological_process node in the Gene Ontology and is frequently used in enrichment analyses of inflammatory and immune-related gene sets.
Description
Interleukin-6 (IL-6) is a multifunctional cytokine that coordinates immune responses, hematopoiesis, and tissue homeostasis. The Gene Ontology term GO:0032675, regulation of interleukin-6 production, captures any process that modulates the frequency, rate, or extent of IL-6 production. Because IL-6 levels are tightly controlled and its dysregulation is linked to diseases ranging from rheumatoid arthritis to cytokine release syndrome and cancer, understanding the regulatory mechanisms is a central goal in immunology and molecular medicine. Researchers use GO:0032675 to annotate genes and pathways that influence IL-6 synthesis, enabling functional enrichment and systems-level analyses. The term encompasses transcriptional, post-transcriptional, and epigenetic control of IL6 gene expression, as well as the signaling cascades that feed into these layers. This article provides a research-grade overview of the ontology, mechanisms, key genes, disease relevance, and experimental methods for studying regulation of interleukin-6 production.
regulation of interleukin-6 production At A Glance
| GO ID | GO:0032675 |
|---|---|
| GO term | regulation of interleukin-6 production |
| Ontology | biological_process |
| Synonym | regulation of IL-6 production; regulation of interleukin-6 biosynthetic process |
| Major function | Modulates the frequency, rate, or extent of interleukin-6 production |
| Related cytokine | Interleukin-6 (IL-6) |
| Key regulators | NF-kB, AP-1, C/EBP-beta, epigenetic modifiers |
| Disease relevance | Inflammation, autoimmunity, cancer, metabolic disease |
| Research methods | CRISPR KO, point mutation, knock-in, overexpression, RNA-seq, proteomics |
What Is GO:0032675?
GO:0032675 is defined as any process that modulates the frequency, rate, or extent of interleukin-6 production. In practical terms, it includes all molecular events that increase or decrease the amount of IL-6 protein synthesized and secreted by a cell, whether through changes in IL6 transcription, mRNA stability, translation, or post-translational processing. The term is a biological_process in the Gene Ontology and has synonyms including regulation of IL-6 production and regulation of interleukin-6 biosynthetic process.
Why Is regulation of interleukin-6 production Important in Cell Biology?
Regulation of interleukin-6 production is critically important because IL-6 is a central mediator of acute and chronic inflammation, and its production must be precisely controlled to avoid tissue damage. Dysregulated IL-6 production contributes to autoimmune diseases, cytokine storms, and tumor progression, making it a major therapeutic target. Understanding the regulatory mechanisms at the GO:0032675 level helps researchers identify causal genes and design interventions that modulate IL-6 levels in specific contexts.
• IL-6 is a pleiotropic cytokine involved in immune defense, hematopoiesis, and metabolism.
• Dysregulated IL-6 production is a hallmark of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
• IL-6 production in the tumor microenvironment can promote cancer cell proliferation and survival.
• Exercise-induced IL-6 production has context-dependent effects on cancer biology.
• Depression and psychological stress can alter IL-6 synthesis, linking neuroimmune interactions to mood disorders.
• IL-6 signaling is a validated target in clinic, with anti-IL-6 receptor antibodies used in therapy.
• Regulation of IL-6 production is important in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD).
• IL-6 production by osteoclast precursors influences bone remodeling and inflammatory bone loss.
• Glomerular mesangial cells produce IL-6 that affects matrix protein production in kidney disease.
• Idiopathic multicentric Castleman disease subtypes show distinct IL-6 production patterns.
What Happens During regulation of interleukin-6 production?
Transcriptional activation of the IL6 gene
In simple terms: The cell receives a signal and switches on the IL6 gene to make more mRNA.
In response to pathogens or inflammatory cytokines, transcription factors such as NF-kB and AP-1 bind to the IL6 promoter and enhancer regions, initiating transcription. This step is a primary point of regulation and determines the potential for IL-6 protein production.
Post-transcriptional regulation of IL6 mRNA
In simple terms: After the mRNA is made, the cell decides how long it survives and how efficiently it is translated.
IL6 mRNA contains AU-rich elements in its 3' untranslated region that control its stability and translation efficiency. RNA-binding proteins and microRNAs can either stabilize or degrade the transcript, thereby modulating IL-6 production.
Epigenetic and chromatin-level control
In simple terms: The way DNA is packaged can make the IL6 gene easier or harder to turn on.
Histone acetylation and DNA methylation at the IL6 locus influence accessibility to transcription factors. Epigenetic modifiers can therefore set the threshold for IL-6 production in different cell types.
Signaling pathways that feed into IL-6 regulation
In simple terms: External signals activate internal cascades that ultimately control IL-6 production.
Pattern recognition receptors, cytokine receptors, and stress sensors activate NF-kB, MAPK, and PI3K-AKT pathways, which converge on the IL6 gene. Myeloid-cell-specific IL-6 signaling can also feed back to modulate production.
Cell-type-specific and context-dependent modulation
In simple terms: Different cells produce IL-6 for different reasons, and the regulation is tailored to the situation.
Macrophages, fibroblasts, endothelial cells, and osteoclast precursors each regulate IL-6 production in response to distinct stimuli. For example, exercise induces IL-6 from skeletal muscle, while depression-associated factors alter IL-6 synthesis in immune cells.
Key Genes Involved in GO:0032675 regulation of interleukin-6 production
The following genes and proteins are central to the regulation of interleukin-6 production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL6 | Encodes interleukin-6 cytokine | Direct target of regulation; knockout and overexpression models |
| NFKB1 | Transcription factor activating IL6 promoter | Key transcriptional regulator; knockout reduces IL-6 production |
| RELA | NF-kB subunit, activates IL6 transcription | Point mutations affect DNA binding and IL-6 levels |
| FOS | AP-1 component, cooperates with NF-kB | Knockout alters IL-6 induction |
| JUN | AP-1 component, regulates IL6 expression | Overexpression increases IL-6 production |
| CEBPB | C/EBP-beta, transcription factor for IL6 | Knock-in models for promoter binding |
| STAT3 | Signal transducer downstream of IL-6 | Feedback regulation of IL-6 production |
| SOCS3 | Suppressor of cytokine signaling | Negative regulator of IL-6 signaling and production |
| TNF | Pro-inflammatory cytokine inducing IL-6 | Knockout reduces IL-6 production |
| IL1B | Induces IL-6 in many cell types | Overexpression models for inflammation |
| TLR4 | Pattern recognition receptor | Knockout abolishes LPS-induced IL-6 |
| MYD88 | Adapter in TLR signaling | Point mutations block IL-6 induction |
| NLRP3 | Inflammasome component | Knockout affects IL-1beta-driven IL-6 |
| MIR223 | MicroRNA regulating IL-6 pathway | Overexpression alters exosome production and IL-6 |
| MMP2 | Matrix metalloproteinase affected by IL-6 | Knockdown changes matrix production |
| MMP9 | Matrix metalloproteinase affected by IL-6 | Knockout models for kidney disease |
| RUNX2 | Transcription factor in osteoclasts | Knock-in for IL-6 response |
| NFATC1 | Osteoclast differentiation factor | Knockout affects IL-6 production |
How Is regulation of interleukin-6 production Regulated?
Regulation of interleukin-6 production is controlled by multiple layers of feedback and feedforward mechanisms. NF-kB and AP-1 are activated by pattern recognition receptors and cytokine receptors, leading to IL6 transcription. Post-transcriptional control via AU-rich elements and microRNAs such as miR-223 modulates mRNA stability and translation. SOCS3 and STAT3 provide negative feedback to limit excessive IL-6 signaling. Epigenetic modifications, including histone acetylation, can either enhance or repress IL6 gene accessibility. In metabolic contexts, myeloid-cell-specific IL-6 signaling promotes miR-223-enriched exosome production to attenuate NAFLD-associated fibrosis. These regulatory circuits ensure that IL-6 production is transient and context-appropriate, but can become dysregulated in disease.
regulation of interleukin-6 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL6 | Inflammatory and autoimmune diseases | Knockout and overexpression cell lines |
| NFKB1 | Chronic inflammation | Point mutation at DNA-binding domain |
| STAT3 | Cancer and autoimmunity | Knock-in of constitutively active STAT3 |
| MIR223 | NAFLD-associated fibrosis | Overexpression of miR-223 in myeloid cells |
| RUNX2 | Osteoclast proliferation and bone loss | Knockout in osteoclast precursors |
Inflammation and autoimmune diseases
Dysregulated IL-6 production is a hallmark of chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease, and idiopathic multicentric Castleman disease. Distinct subtypes of Castleman disease show different IL-6 production patterns, highlighting the clinical heterogeneity. Targeting IL-6 signaling has become a validated therapeutic strategy in clinic.
Cancer
IL-6 produced in the tumor microenvironment can promote cancer cell proliferation, survival, and metastasis. Exercise-induced IL-6 has context-dependent effects on cancer biology, with some studies suggesting anti-tumor roles. Regulation of IL-6 production is therefore a potential target for cancer therapy.
Metabolic and liver diseases
Myeloid-cell-specific IL-6 signaling promotes miR-223-enriched exosome production to attenuate NAFLD-associated fibrosis. This indicates that regulation of IL-6 production in specific cell types can have protective or pathogenic roles in metabolic liver disease.
Neuropsychiatric and bone disorders
Depression affects IL-6 synthesis, linking neuroimmune interactions to mood disorders. IL-6 transiently promotes proliferation of osteoclast precursors and stimulates production of inflammatory mediators, contributing to bone loss. Glomerular mesangial cells produce IL-6 that influences matrix protein production in kidney disease.
From regulation of interleukin-6 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IL-6 production? | CRISPR knockout cell line |
| Does a specific mutation affect IL-6 regulation? | Point mutation knock-in |
| How does a tag affect IL-6 production? | Tagged knock-in |
| Does overexpression of gene Y increase IL-6? | Overexpression cell line |
| Which genes are essential for IL-6 regulation? | CRISPR library screening |
| What pathways are enriched in IL-6 regulation? | Bioinformatics analysis |
How to Study the regulation of interleukin-6 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of IL6 and related genes | Transcriptional regulation studies |
| ELISA | Secreted IL-6 protein | Quantification of production |
| Western blot | Intracellular IL-6 protein | Validation of regulation |
| ChIP-seq | Transcription factor binding at IL6 locus | Identify regulators |
| ATAC-seq | Chromatin accessibility | Epigenetic regulation |
| CRISPR screen | Genes affecting IL-6 production | Functional genomics |
| Bioinformatics | Enrichment of GO:0032675 | Pathway analysis |
Transcriptional profiling
RNA-seq and qPCR are used to measure IL6 mRNA levels and identify transcriptional changes in response to stimuli. These methods help determine whether regulation occurs at the transcriptional level.
Protein quantification
ELISA and Western blot are standard methods to measure secreted and intracellular IL-6 protein levels. These assays are essential for confirming functional changes in IL-6 production.
Epigenetic and chromatin analysis
ChIP-seq and ATAC-seq can assess histone modifications and chromatin accessibility at the IL6 locus. These techniques reveal epigenetic mechanisms of regulation.
Functional genomics screens
CRISPR knockout and activation screens can identify genes that regulate IL-6 production at a genome-wide scale. Bioinformatics pipelines are then used to analyze enrichment of GO terms such as GO:0032675.
How CRISPR Can Be Used to Study GO:0032675 regulation of interleukin-6 production
Knockout
CRISPR knockout of candidate genes such as NFKB1 or IL6 itself can determine whether they are required for IL-6 production. Knockout cell lines provide a clean background to test regulatory mechanisms.
Point Mutation
Point mutations can be introduced into transcription factor binding sites or coding regions to assess the impact on IL-6 regulation. This approach helps dissect specific residues or motifs.
Knock-in
Knock-in of tagged IL6 or reporter constructs allows real-time monitoring of IL-6 production. Knock-in models can also introduce disease-associated variants.
Overexpression
Overexpression of regulators such as STAT3 or miR-223 can test sufficiency in driving IL-6 production changes. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports regulation of interleukin-6 production Research
Researchers studying regulation of interleukin-6 production-related genes often need to determine whether a candidate gene is causally involved in modulating IL-6 levels. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-6 production research.
Frequently Asked Questions About regulation of interleukin-6 production
What is GO:0032675?
GO:0032675 is the Gene Ontology term for regulation of interleukin-6 production, defined as any process that modulates the frequency, rate, or extent of IL-6 production.
What genes are involved in regulation of interleukin-6 production?
Key genes include IL6, NFKB1, RELA, FOS, JUN, CEBPB, STAT3, SOCS3, and MIR223, among others.
How is IL-6 production regulated?
IL-6 production is regulated at transcriptional, post-transcriptional, and epigenetic levels by factors such as NF-kB, AP-1, and microRNAs.
What diseases are associated with dysregulated IL-6 production?
Dysregulated IL-6 production is associated with autoimmune diseases, cancer, NAFLD, depression, and Castleman disease.
What experimental models are used to study IL-6 regulation?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as CRISPR screens, are commonly used.
How can I measure IL-6 production?
ELISA, Western blot, and RNA-seq are standard methods to measure IL-6 protein and mRNA levels.
What is the role of NF-kB in IL-6 production?
NF-kB is a transcription factor that binds to the IL6 promoter and activates its transcription.
Can exercise affect IL-6 production?
Yes, exercise induces IL-6 production from skeletal muscle, with context-dependent effects on cancer biology.
What is the link between depression and IL-6?
Depression can affect IL-6 synthesis, linking neuroimmune interactions to mood disorders.
How does IL-6 contribute to NAFLD?
Myeloid-cell-specific IL-6 signaling promotes miR-223-enriched exosome production to attenuate NAFLD-associated fibrosis.
Conclusion
GO:0032675 regulation of interleukin-6 production is a fundamental biological process that controls the synthesis of a pleiotropic cytokine. Its dysregulation underlies numerous diseases, making it a key area of research. Understanding the genes and mechanisms involved provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to accelerate discoveries in this field.
References
- 1. Tanaka T et al.. 2016. Regulation of IL-6 in Immunity and Diseases.. Adv Exp Med Biol 941:79-88 PMID: 27734409
- 2. Kang S et al.. 2019. Targeting Interleukin-6 Signaling in Clinic.. Immunity 50(4):1007-1023 PMID: 30995492
- 3. Orange ST et al.. 2023. The exercise IL-6 enigma in cancer.. Trends Endocrinol Metab 34(11):749-763 PMID: 37633799
- 4. Nishikori A et al.. 2026. Distinct interleukin-6 production in IPL and TAFRO subtypes of idiopathic multicentric Castleman disease.. Haematologica 111(5):1705-1715 PMID: 40931874
- 5. Chang PY et al.. 2022. Interleukin-6 transiently promotes proliferation of osteoclast precursors and stimulates the production of inflammatory mediators.. Mol Biol Rep 49(5):3927-3937 PMID: 35218446
- 6. Chaudhari S et al.. 2020. Inhibition of interleukin-6 on matrix protein production by glomerular mesangial cells and the pathway involved.. Am J Physiol Renal Physiol 318(6):F1478-F1488 PMID: 32390515
- 7. Hou X et al.. 2021. Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.. Hepatology 74(1):116-132 PMID: 33236445
- 8. Zadka Ł et al.. 2017. Clinical Phenotype of Depression Affects Interleukin-6 Synthesis.. J Interferon Cytokine Res 37(6):231-245 PMID: 28418766
